PG Course-LV
Nov. 15 (Thu)
09:00-10:30
Recent progress in the management of chronic liver diseases 103
Chairperson(s) Jidong Jia, Jin Mo Yang
09:00-09:20 Strategies for complete cure of HBV infection beyond strong antiviral suppressive treatment TBA
09:20-09:40 Update of pharmacological therapies in nonalcoholic fatty liver disease David Q.-H. Wang
(New York)
09:40-10:00 Recent updates in the management of cirrhosis complication: SBP, ascites and varix bleeding Ashish Kumar
(New Delhi)
10:00-10:20 Differences in HCC treatment strategies: Eastern vs Western Perspectives Joong Won Park
(Goyang)
10:20-10:30 Q&As
Sex and Gender Specific Medicine Session
Nov. 15 (Thu)
09:00-10:30
Sex and gender specific medicine session 105
Chairperson(s) Eamonn Quigley, Na Young Kim
09:00-10:30 Eamonn Quigley
(Houston)
09:00-10:30 Na Young Kim
(Seongnam)
09:00-10:30 Gender difference in gastrointestinal function and functional GI disorders Hidekazu Suzuki
(Tokyo)
09:00-10:30 Sex and gender specific IBS TBA
09:00-10:30 Gender, the microbiome and the microbiome-gut-brain axis Eamonn Quigley
(Houston)
09:00-10:30 Work-Life conflict and its health effects on Korean gastroenterologist according to age and sex Eun Sun Jang
(Seongnam)
09:00-10:30 Panel discussion
Symposium GI-1 (UG)
Nov. 15 (Thu)
09:00-10:30
Prevention of gastric cancer 203
Chairperson(s) Sang Young Seol, Jae J. Kim
09:00-09:20 Primary prevention: role of H. pylori eradication TBA
09:20-09:40 Secondary prevention: role of H. pylori eradication after endoscopic resection of gastric epithelial neoplasia Hiroto Miwa
(Nishinomiya)
09:40-10:00 Secondary prevention: role of H. pylori eradication after partial gastrectomy Da Hyun Jung
(Seoul)
10:00-10:20 Chemoprevention of gastric cancer other than H. pylori eradication Soo-Jeong Cho
(Goyang)
10:20-10:30 Q&As
KDDW PG Course-PB (K)
Nov. 15 (Thu)
09:00-10:30
Recent advances and problems in the management of pancreatobiliary disease E1+2
Chairperson(s) TBA, TBA
09:00-09:20 Pancreatobiliary maljunction: diagnostic criteria and proper management TBA
09:20-09:40 Optimal management of intrahepatic duct stones Chang Hwan Park
(Gwangju)
09:40-10:00 Recent advances in the management of advanced pancreatic neuroendocrine tumor Chang-Min Cho
(Daegu)
10:00-10:20 Endoscopic management of biliary complication after liver transplantation Jimin Han
(Daegu)
10:20-10:30 Q&As
PG Course-PB
Nov. 15 (Thu)
11:00-12:30
Pancreatobiliary endoscopy in challenging situations 103
Chairperson(s) Yong-Tae Kim, Jin Hong Kim
11:00-11:20 Acute severe pancreatitis; Initial management, Indications, timing and therapeutic modalities for drainage D. Nageshwar Reddy
(Hyderabad)
11:20-11:40 Pancreatic cystic neoplasm; Differential diagnosis, management & surveillance TBA
11:40-12:00 Bile duct stones and complications; Indication, timing and role of EUS, ERCP and cholecystectomy Masayuki Kitano
(Hong Kong)
12:00-12:20 Cholangiocarcinoma; Diagnosis, staging and pre-operative tissue acquisition and stenting. TBA
12:20-12:30 Q&As
KDDW Symposium LV-1 (K)
Nov. 15 (Thu)
11:00-12:30
Changing paradigms in the the management of chronic liver disease 105
Chairperson(s) TBA, Han Chu Lee
Combined-1 (Nutrition)
Nov. 15 (Thu)
11:00-12:30
Optimal nutritional support in various clinical situations 201
Chairperson(s) TBA, Hyun Wook Baik, Byung-Ho Choe
11:00-11:20 Perioperative period: enteral and parenteral nutrition TBA
11:20-11:40 Gastrointestinal cancer patients who are not candidates for surgery: when to treat and when to stop TBA
11:40-12:00 Chronic pancreatitis: the timing of nutritional intervention and therapeutic goal TBA
12:00-12:20 Inflammatory bowel disease: nutrition in acute exacerbation and as long-term care TBA
12:20-12:30 Q&As
Symposium GI-2 (Motility)
Nov. 15 (Thu)
11:00-12:30
Dyspepsia: what’s new in 2018? (ANMA-KSNM joint session) 203
Chairperson(s) Hyo Jin Park, TBA
11:00-11:20 Epidemiology of functional dyspepsia in Asia Hyo Jin Park
(Seoul)
11:20-11:40 New pathogenesis of functional dyspepsia Kwang Jae Lee
(Suwon)
11:40-12:00 Helicobacter pylori-associated dyspepsia Kentaro Sugano
(Shimotsukei)
12:00-12:20 Novel treatment of dyspepsia Justin C.Y. Wu
(Hong Kong)
12:20-12:30 Q&As
KDDW PG Course-GI Cancer (K)
Nov. 15 (Thu)
11:00-12:30
Update and change of health insurance coverage for gastrointestinal cancer in Korea 2018 E1+2
Chairperson(s) Kwang Ro Joo, TBA
11:00-11:20 Esophageal / stomach cancer Hee Seok Moon
(Daejeon)
11:20-11:40 Colorectal cancer TBA
11:40-12:00 Pancreatobiliary cancer Sang Myung Woo
(Goyang)
12:00-12:20 Palliative care for gastrointestinal cancer - pain, anti-emetics, nutrition Jin Seok Jang
(Busan)
12:20-12:30 Q&As
PG Course-UG
Nov. 15 (Thu)
14:00-15:30
Overview of recent progress in upper GI diseases 103
Chairperson(s) Jaw-Town Lin, TBA
14:00-14:20 Diagnosis and treatment of GERD Sabine Roman 
(Lyon)
14:20-14:40 Management of peptic ulcer disease Joseph JY Sung
(Hong Kong)
14:40-15:00 Helicobacter pylori eradication in Asia-Pacific regions Jaw-Town Lin
(Taipei)
15:00-15:20 Effect of screening endoscopy for gastric cancer in regions where Helicobacter pylori is prevalent TBA
15:20-15:30 Q&As
KDDW Symposium LV-2 (K)
Nov. 15 (Thu)
14:00-15:30
Genral review of rare liver diseases 105
Chairperson(s) TBA, TBA
Combined-2 (UGI-LGI)
Nov. 15 (Thu)
14:00-15:30
NSAIDs-induced GI injury 201
Chairperson(s) Wai-keung Leung, TBA
14:00-14:20 Pathophysiology Jaeyoung Chun
(Seoul)
14:20-14:40 NSAIDs-associated upper GI disease TBA
14:40-15:00 NSAIDs-associated lower GI disease Wai-keung Leung
(Hong Kong)
15:00-15:20 Prevention and treatment Seong Woo Jeon
(Daegu)
15:20-15:30 Q&As
KDDW PG Course-Motility (K)
Nov. 15 (Thu)
14:00-15:30
변비 완전 정복 (A to Z of constipation) (전공의 및 전임의 대상 PG 코스, 한글) E1+2
Chairperson(s) Sei Jin Youn, Joon Seong Lee
14:00-14:20 병태생리 (Pathophysiology) TBA
14:20-14:40 진단 (Assessment) Joon Seong Lee
(Seoul)
14:40-15:00 약물치료 (Pharmacologic treatment) TBA
15:00-15:20 비약물치료 (Nonpharmacologic treatment) TBA
15:20-15:30 Q&As
PG Course-LG
Nov. 15 (Thu)
16:00-17:30
Recent update in lower GI diseases 103
Chairperson(s) Peter R. Gibson, Tae Il Kim
16:00-16:20 The cutting edge strategy for the treatment of inflammatory bowel disease therapy Choon-jin Ooi
(Singapore)
16:20-16:40 Quality issues in colonoscopic screening for colorectal cancer Uri Ladabaum
(Stanford)
16:40-17:00 Treatment of IBD: low-FODMAP diet and beyond Peter R. Gibson
(Melbourne)
17:00-17:20 Upates in diagnosis and treatment for Clostridium difficile infection You Sun Kim
(Seoul)
17:20-17:30 Q&As
KDDW Symposium LV-3 (K)
Nov. 15 (Thu)
16:00-17:30
Management of cormobidity in liver disease 105
Chairperson(s)
Symposium GI-3 (LG)
Nov. 15 (Thu)
16:00-17:30
Recent progress on translational research in colorectal neoplasm 203
Chairperson(s) TBA, Joseph JY Sung
15:20-15:30 Q&As
16:00-16:20 Novel biomarkers of noninvasive diagnosis of colorectal cancer: Fecal microbiota Joseph JY Sung
(Hong Kong)
16:20-16:40 Optimal strategy of colorectal cancer screening in Asia TBA
16:40-17:00 Emerging imaging techniques for colorectal neoplasm Seung-Jae Myung
(Seoul)
17:00-17:20 New targeting agents for treatment of colorectal neoplasm TBA
KDDW PG Course-UG (K)
Nov. 15 (Thu)
16:00-17:30
PG Course-UG (K) E1+2
Chairperson(s) Jong Sun Rew, TBA
15:20-15:30 Q&As
16:00-16:20 소화성궤양 합병증: 어떻게 대처할 것인가? Ju Yup Lee
(Daegu)
16:20-16:40 조기위암의 내시경적 절제술: 그 다음 이야기 TBA
16:40-17:00 불응성 역류성 식도염: 무엇을 더 해야 하나? TBA
17:00-17:20 위축성위염, 장상피화생, 그리고 이형성: 단계별 추적검사 Woo Chul Chung
(Suwon)
Symposium EN-1 (UG)
Nov. 16 (Fri)
08:30-10:00
Minimal invasive therapy of early gastric cancer: from ESD to surgery 101
Chairperson(s) Hyung-Ho Kim, Enqiang Linghu, Seigo Kitano
08:30-08:50 How to choose a patient with early gastric cancer who can be treated with endoscopic submucosal dissection Enqiang Linghu
(Beijing)
08:50-09:10 ESD for early gastric cancer with undifferentiated histology: do we have enough data? TBA
09:10-09:30 Risk stratification of noncurative ESD: do all patient need additional treatment? TBA
09:30-09:50 Sentinel node navigation surgery for early gastric cancer: when and how to perform? Masanori Terashima
(Shizuoka)
09:50-10:00 Q&As
Symposium EN-2 (LG)
Nov. 16 (Fri)
08:30-10:00
Progress in the detection and management of colorectal neoplasm 102
Chairperson(s) Hermann Brenner, TBA
08:30-08:50 Image enhanced endoscopy in colorectal cancer screening: current status Wai-keung Leung
(Hong Kong)
08:50-09:10 Computer-aided detection and histopathology prediction for colorectal polyps Jeong-sik Byeon
(Seoul)
09:10-09:30 Detection and removal of serrated lesions Hyo Joon Yang
(Seoul)
09:30-09:50 Recent advances in colorectal ESD Takahisa Matsuda
(Tokyo)
09:50-10:00 Q&As
Symposium LV-1
Nov. 16 (Fri)
08:30-10:00
Chronic hepatitis B: current medication 103
Chairperson(s) TBA, TBA
08:30-08:50 Can we stop the neucleot(s)ide analogue? TBA
08:50-09:10 Prevention of new HBV infection: nucleotide analogue in pregnant women and vaccination Henry LY Chan
(Hong Kong)
09:10-09:30 HBV and HCV coinfection Jidong Jia
(Beijing)
09:30-09:50 Bepatitis B prophylaxis and occult hepatitis B in immunocompromized patients: to whom and how long Seng-Gee Lim
(Singapore)
09:50-10:00 Q&As
Symposium PB-1
Nov. 16 (Fri)
08:30-10:00
New insights in the biliary system 104
Chairperson(s) D. Nageshwar Reddy, TBA, TBA
08:30-08:50 Optimal evaluation of premalignant biliary lesions TBA
08:50-09:10 Optimal approach to the indeterminate bile duct stricture Hsiu-Po Wang
(Taipei)
09:10-09:30 Updates on difficult biliary stones management Amit Maydeo
(Mumbai)
09:30-09:50 Best Endoscopic drainage of biliary system. TBA
09:50-10:00 Q&As
Symposium GI-4 (Motility)
Nov. 16 (Fri)
08:30-10:00
Updates in gastrointestinal neurogastro-motility disorders 105
Chairperson(s) Nicholas Talley, Kwang Jae Lee
08:30-08:50 Approach to esophageal disorders John E Pandolfino
(Chicago)
08:50-09:10 Approach to gastric disorders Nicholas Talley
(Callaghan)
09:10-09:30 Approach to bowel disorders Eamonn MM Quigley
(Houston)
09:30-09:50 Differences of guidelines between Asia and West TBA
09:50-10:00 Q&As
SIDDS 1
Nov. 16 (Fri)
08:30-10:00
Understanding of molecular alteration: the cornerstone for treatment of GI cancer 202
Chairperson(s) TBA, TBA
08:30-08:55 The mechanisms responsible for the development of pre-neoplastic lineages from metaplasias in the stomach and their roles in gastric carcinogenesis James Goldenring
(Nashville)
08:55-09:20 Proteogenomics for understanding of GI cancer Youngsoo Kim
(Seoul)
09:20-09:45 Control of GI cancer using CRIPR-Cas9 TBA
09:40-10:00 Q&As
Symposium EN-3 (UG)
Nov. 16 (Fri)
08:30-10:00
Recent update in treatment for GI subepithelial tumors 203
Chairperson(s) TBA, Seigo Kitano
08:30-08:50 Resection for subepithelial tumors: when is it needed? Jie-Hyun Kim
(Seoul)
08:50-09:10 Endoscopic resection of subepithelial tumors via standard EMR/ESD technique TBA
09:10-09:30 Endoscopic full thickness resection of subepithelial tumors TBA
09:30-09:50 Minimally invasive surgery for subepithelial tumors Osamu Goto
(Tokyo)
09:50-10:00 Q&As
KDDW PG Course-LV (K)
Nov. 16 (Fri)
08:30-10:00
Concerning points and management during treatment for liver disease E1+2
Chairperson(s) TBA, So Young Kwon
08:30-08:50 During antiviral therapy for HBV TBA
08:50-09:10 During antiviral therapy for HCV In Hee Kim
(Jeonju)
09:10-09:30 During imunosuppressive therapy for Autoimmune liver disease TBA
09:30-09:50 During systemic therapy for HCC Sung-Bum Cho
(Gwangju)
09:50-10:00 Q&As
KDDW PG Course-Endoscopy (K)
Nov. 16 (Fri)
10:30-12:00
Basic drainage technique of Pancreatobiliary diseases (PG course) E1+2
Chairperson(s) TBA, TBA
10:30-10:50 Biliary drainage: benign and malignant distal biliary obstruction TBA
10:50-11:10 Biliary drainage: advanced hilar obstruction Tae Hoon Lee
(Cheonan)
11:10-11:30 Obstructed pancreatic duct drainage: transpapillary and EUS-guided drainage TBA
11:30-11:50 Gallbladder drainage: transpapillary and transmural drainage TBA
11:50-12:00 Q&As
Okuda Lectureship
Nov. 16 (Fri)
11:00-11:30
Okuda Lectureship Auditorium
Chairperson(s) TBA, TBA
11:00-11:30 Challenges of Hepatitis B in the Era of Antiviral Therapy Henry LY Chan
(Hong Kong)
Marshall & Warren Lectureship
Nov. 16 (Fri)
11:30-12:00
Marshall & Warren Lectureship Auditorium
Chairperson(s) TBA, TBA
11:30-12:00 Chemoprevention of Gastric Cancer by H. pylori Eradication and its Underlying Mechanism Nayoung Kim
(Bundang)
Symposium GI-5 (UG)
Nov. 16 (Fri)
14:00-15:30
Gastric carcinogenesis: Host, microbiome, and their interactions 101
Chairperson(s) Kwong-ming Fock, TBA
14:00-14:20 Identification of genetic susceptibility for gastric cancer through genome-wide association studies Benjamin Wong
(Hong Kong)
14:20-14:40 Non-coding RNA and gastric cancer TBA
14:40-15:00 Interactions between human and Helicobacter pylori in gastric carcinogenesis Richard Peek
(Nashville)
15:00-15:20 Non-Helicobacter pylori microbiome in gastric carcinogenesis Yoshio Yamaoka
(Oita)
15:20-15:30 Q&As
Symposium EN-4 (UG)
Nov. 16 (Fri)
14:00-15:30
Recent advances of EUS: one more step 102
Chairperson(s) Laurent Palazzo, TBA
14:00-14:20 Enhanced EUS imaging: Elastography and contrast enhanced EUS Laurent Palazzo
(Paris)
14:20-14:40 EUS-FNA/FNB in the gastrointestinal tract TBA
14:40-15:00 Present status of EUS in pancreatic cystic lesions Yousuke Nakai
(Tokyo)
15:00-15:20 Interpretation of EUS-FNA/FNB specimen: Pathologist’s view Kee-Taek Jang
(Seoul)
15:20-15:30 Q&As
Symposium LV-2
Nov. 16 (Fri)
14:00-15:30
Chronic hepatitis B: future treatment for the cure 103
Chairperson(s) TBA, Shiv K. Sarin
14:00-14:20 Potential therapeutic target in hepatitis B virus life cycle Jia-Horng Kao
(Taipei)
14:20-14:40 New antiviral strategy to?combat with cccDNA and hepato-carcinogenesis TBA
14:40-15:00 Immunologic modulation for hepatitis B treatment Antonio Bertoletti
(Singapore)
15:00-15:20 Emerging drugs?& new therapeutic perspectives?for HBV Henry LY Chan
(Hong Kong)
15:20-15:30 Q&As
Symposium PB-2
Nov. 16 (Fri)
14:00-15:30
Cutting edge of pancreatic diseases 104
Chairperson(s) Chengwei Tang, Hsiu-Po Wang
14:00-14:20 TBA Chengwei Tang
(Chengdu)
14:20-14:40 Pancreatic enzyme replacement therapy in chronic pancreatitis TBA
14:40-15:00 Updates on Ig G4 related diseases Kazuichi Okazaki
(Osaka)
15:00-15:20 Current status of pancreatic cystic neoplasm management TBA
15:20-15:30 Q&As
Combined-3 (Liver, PB)
Nov. 16 (Fri)
14:00-15:30
Autoimmune diseases of the liver and biliary system: the essentials 105
Chairperson(s) Myung-Hwan Kim, Sook-Hyang Jeong
14:00-14:20 Autoimmune hepatitis - 2018 Update Atsushi Tanaka
(Tokyo)
14:20-14:40 Primary biliary cholangitis: from diagnosis to treatment Kyung -Ah Kim
(Goyang)
14:40-15:00 Primary sclerosing cholangitis: what is the best management in the 21stcentury? TBA
15:00-15:20 IgG4-related sclerosing cholangitis: when to suspect, how to diagnose, and how to treat Tae Jun Song
(Seoul)
15:20-15:30 Q&As
Symposium GI-6 (LG)
Nov. 16 (Fri)
14:00-15:30
Shifting paradigm in IBD management 202
Chairperson(s) Joo Sung Kim, Siew C Ng
14:00-14:20 New drugs on the horizon: Targeting cytokines, cell trafficking, and more Choon-jin Ooi
(Singapore)
14:20-14:40 Fecal microbiota transplantation for IBD: Ready to use? Siew C Ng
(Hong Kong)
14:40-15:00 Toward improving quality of care in IBD management David T Rubin
(Chicago)
15:00-15:20 Things you should know when managing elderly IBD patients Jae Hee Cheon
(Seoul)
15:20-15:30 Q&As
Symposium EN-5 (UG)
Nov. 16 (Fri)
14:00-15:30
Current status and future direction for early esophageal cancer treatment strategy 203
Chairperson(s) TBA, Tsuneo Oyama
14:00-14:20 High magnification and NBI imaging endoscopy for early esophageal cancer TBA
14:20-14:40 ESD with multimodal treatment for esophageal cancer Tsuneo Oyama
(Saku)
14:40-15:00 Ablation therapy for esophageal cancer: when and how? TBA
15:00-15:20 Management of esophageal stricture after endoscopic treatment TBA
15:20-15:30 Q&As
Symposium GI-7 (GI Cancer)
Nov. 16 (Fri)
14:00-15:30
Gastirc cancer, are we in new era for management? E1+2
Chairperson(s) TBA, James Goldenring
14:00-14:20 The global change in epidemiology of gastric cancer TBA
14:20-14:40 Role of?SPEM in gastric carcinogenesis James Goldenring
(Nashville)
14:40-15:00 Do we have proper surgical modalities to preserve functional aspect after gastric cancer surgery? Keun Won Ryu
(Goyang)
15:00-15:20 Current treatment landscape and future perspectives in patients with advanced gastric cancer Sung Eun Kim
(Busan)
15:20-15:30 Q&As
AGA-APAGE
Nov. 16 (Fri)
16:00-18:00
From bench to clinic in gastric cancer: Where are we headed? 101
Chairperson(s) Emad El-Omar, TBA
16:00-16:25 The molecular pathogenesis of gastric cancer ? state of the art Timothy Wang
(New York)
16:25-16:50 The role of the gastric microbiome in H. pylori-induced gastric cancer Richard Peek
(Nashville)
16:50-17:15 Prevention of gastric cancer ? opportunities and potential problems Kentaro Sugano
(Shimotsukei)
17:15-17:40 National gastric cancer screening- outcomes and future challenges TBA
17:40-18:00 Q&As
Symposium GI-8 (LG)
Nov. 16 (Fri)
16:00-17:30
The cutting edge issues in management of IBD 2018 102
Chairperson(s) TBA, Jiaming Qian
16:00-16:20 What should be the therapeutic targets in IBD therapy? Siew C Ng
(Hong Kong)
16:20-16:40 Proper positioning of various drugs in therapeutic algorithm David T Rubin
(Chicago)
16:40-17:00 Place of TDM in optimal use of biologics Akira Andoh
(Shiga)
17:00-17:20 Managing Crohn's disease after surgery TBA
17:20-17:30 Q&As
Symposium LV-3
Nov. 16 (Fri)
16:00-17:30
Chronic hepatitis C in DAA era 103
Chairperson(s) Kwan Soo Byun, Rakesh Aggarwal
16:00-16:20 HCV screening in general population: is this cost-effective in DAA era? Rakesh Aggarwal
(Lucknow)
16:20-16:40 Is there difficult to treat population in HCV patients in DAA era? TBA
16:40-17:00 Increased risk of HCC following DAA: fact or fiction?/Follow up strategy after SVR in chronic hepatitis C Yasuhito Asahina
(Tokyo)
17:00-17:20 DAA first versus transplantation first in decompensated cirrhotic HCV patients or Optimal treatment strategy for naive and previous DAA failure CHC patients Young Suk Lim
(Seoul)
17:20-17:30 Q&As
WEO Honorary Lectureship
Nov. 16 (Fri)
16:00-17:00
WEO Honorary Lectureship 104
Chairperson(s) TBA, TBA
16:00-16:50 The future of globalization of advanced endoscopy Hisao Tajiri
(Tokyo)
16:50-17:00 Q&A
Combined-4 (Endoscopy-Surgery)
Nov. 16 (Fri)
16:00-17:30
Gastrointestinal diseases and treatments in obese patients (KSGE combined session) 105
Chairperson(s) TBA, TBA
16:00-16:20 Functional gastrointestinal disorders in obese patients Yong Sung Kim
(Iksan)
16:20-16:40 Gastrointestinal tumors associated with obesity Jin-Hyeok Hwang
(Seongnam)
16:40-17:00 Endoscopic treatments for morbid obesity Hyuk Soon Choi
(Seoul)
17:00-17:20 Surgical treatments for morbid obesity Takeshi Naitoh
(Sendai)
17:20-17:30 Q&As
Symposium GI-9 (UG)
Nov. 16 (Fri)
16:00-17:30
All about GIST on UGI tract 202
Chairperson(s) TBA, Byung-Wook Kim
16:00-16:20 Pathologic diagnosis; focused on prognostic factor TBA
16:20-16:40 Endoscopic treatment: when and how? TBA
16:40-17:00 Surgical treatment: when and how? TBA
17:00-17:20 Target therapy: when and how? Dong-Hoe Koo
(Seoul)
17:20-17:30 Q&As
Symspoium PB-3
Nov. 16 (Fri)
16:00-17:30
Recent advances in intra- and extrahepatic cholangiocarcinoma: promising or practice changing? 203
Chairperson(s) TBA, Ji-kon Ryu
16:00-16:20 Pathogenesis and molecular characterization: from genetics to signaling pathways Young Nyun Park
(Seoul)
16:20-16:40 Pathologic classification: new concepts TBA
16:40-17:00 Endoscopic management: from ERCP to EUS Masayuki kitano
(Wakayama)
17:00-17:20 Selection of patients for curative resection and role of surgery: from resection to transplantation TBA
17:20-17:30 Dong Hee Koh
(Hwaseong)
KDDW PG Course-LG (K)
Nov. 16 (Fri)
16:00-17:30
Current status and future perspectives in management of small bowel diseases E1+2
Chairperson(s) Hyun Soo Kim, TBA
16:00-16:20 Optimal approach to small bowel bleeding (소장 출혈의 원인과 진단) TBA
16:20-16:40 Radiologic diagnosis of small bowel diseases (소장 질환의 영상학 진단) TBA
16:40-17:00 Therapeutic role of enteroscopy (소장내시경의 소장 질환에서 치료 역할) Sung Noh Hong
(Seoul)
17:00-17:20 Interesting cases of various small bowel diseases (다양한 소장질환의 증례 소개 및 증례 관련 간단요약 - 역학/진단/치료) TBA
17:20-17:30 Q&As
Symposium LV-4
Nov. 17 (Sat)
08:30-10:00
Current advances in non-alcoholic fatty liver disease 101
Chairperson(s) TBA, George Jacob
08:30-08:50 New trends on obesity and NAFLD in Asia Vincent Wong
(Hong Kong)
08:50-09:10 Interactions between bile acids and nuclear receptors in NAFLD David Q.-H. Wang
(New York)
09:10-09:30 Clinical trial design and optimal endpoints for nonalcoholic steatohepatitis TBA
09:30-09:50 Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease George Jacob
(Sydney)
09:50-10:00 Q&As
Symposium GI-10 (LG)
Nov. 17 (Sat)
08:30-10:00
Updates on the management of gastrointestinal bleeding 102
Chairperson(s) Toshiyuki Matsui, Michael Li, Joo Sung Kim
08:30-08:50 Treatment of peptic ulcer bleeding: present and future TBA
08:50-09:10 Diagnostic approach for obscure gastrointestinal bleeding Ki-Nam Shim
(Seoul)
09:10-09:30 Endoscopic management of colonic diverticular bleeding Hiroshi Kashida
(Osaka)
09:30-09:50 Treatment and prevention of Variceal bleeding Shiv K. Sarin
(New Delhi)
09:50-10:00 Q&As
Symposium EN-6 (PB)
Nov. 17 (Sat)
08:30-10:00
Pancreatobiliary endoscopy in challenging situations 104
Chairperson(s) TBA, Ari Fahrial Syam
08:30-08:50 How to minimize ERCP complications Hiroyuki Isayama
(Tokyo)
08:50-09:10 Updates of cholangioscopy for the diagnosis and treatment of biliary tract cancer Jong Ho Moon
(Bucheon)
09:10-09:30 ERCP for patients with altered gastrointestinal anatomy TBA
09:30-09:50 Endoscopic Resecure Management after Surgical complications TBA
09:50-10:00 Q&As
Symposium SM-1
Nov. 17 (Sat)
08:30-10:00
Multidisciplinary approach to perihilar cholangiocarcinoma 105
Chairperson(s) Alfred Kow, Ho Gak Kim
08:30-08:50 Diagnosis and intervention: radiologist's perspective TBA
08:50-09:10 Diagnosis and intervention: endoscopist's perspective TBA
09:10-09:30 What is the adequate extent of surgery for Bismuth type I or II perihilar cholangiocarcinoma Masayuki Ohtsuka
(Chiba)
09:30-09:50 Extensive resection of perihilar cholangiocarcinoma TBA
09:50-10:00 Q&As
Symposium EN-7 (LG)
Nov. 17 (Sat)
08:30-10:00
Early colorectal cancer: a smart approach and optimal treatment 202
Chairperson(s) TBA, TBA, Woo Yong Lee
08:30-08:50 Best approach for predicting deep SM invasion TBA
08:50-09:10 New device and advanced technique of colorectal ESD Takahisa Matsuda
(Tokyo)
09:10-09:30 Minimal invasive surgery for early colorectal cancer: Role and Future TBA
09:30-09:50 Optimal surveillance strategy for early colorectal cancer TBA
09:50-10:00 Q&As
Symspoium PB-4
Nov. 17 (Sat)
08:30-10:00
Gallbladder disease: unsolved problems revisited 203
Chairperson(s) Jong Kyun Lee, TBA
08:30-08:50 What are the true risk factors and precursors to gallbladder cancer? TBA
08:50-09:10 Differential diagnosis between gallbladder cancer and benign gallbladder disease TBA
09:10-09:30 Endoscopic gallbladder drainage compared with percutaneous drainage: advantages and limitations TBA
09:30-09:50 Surgical strategies for acute cholecystitis in the era of minimal invasive approach: when and how? Keun Soo Ahn
(Daegu)
09:50-10:00 Q&As
Emerging Leader Lectureship 1
Nov. 17 (Sat)
11:00-11:30
Emerging Leader Lectureship 1 Auditorium
Chairperson(s) TBA, TBA
11:00-11:30 Establishment of an organoid bank of biliary tract and pancreatic cancers and its application for personalized therapy Yoshimasa Saito
(Japan)
Emerging Leader Lectureship 2
Nov. 17 (Sat)
11:30-12:00
Emerging Leader Lectureship 2 Auditorium
Chairperson(s) TBA, TBA
11:30-12:00 Disease outcomes of chronic hepatitis B in the era of nucleoside analogue therapy Wai-Kay Walter Seto
(Hong Kong)
Symposium LV-5
Nov. 17 (Sat)
10:30-12:00
Recent advances in the management of hepatocellular carcinoma 101
Chairperson(s) Joong Won Park, Jose D Sollano
10:30-10:50 Multidisciplinary approach in HCC treatment: various combination strategies and new emerging MTAs in HCC treatment Masao Omata
(Tokyo)
10:50-11:10 Application of new local ablation therapies in HCC: microwave RFA, cryotherapy, etc TBA
11:10-11:30 Comparision of transarterial approaches in HCC treatment: conventional TACE, DEB-TACE vs TARE 혹은 Conventional TACE versus new upcoming transarterial treatments in HCC? Jin Wook Chung
(Seoul)
11:30-11:50 Immunotherapeutic approaches beyond molecular targeted agents in HCC Thomas Yau
(Hong Kong)
11:50-12:00 Q&As
Symposium EN-8 (UG)
Nov. 17 (Sat)
10:30-12:00
Endoscopic treatment for EGJ diseases 103
Chairperson(s) TBA, John E. Pandolfino
10:30-10:50 POEM in achalasia: Redo-POEM after failed POEM TBA
10:50-11:10 Beyond achalasia in POEM: hypercontractile esophageal disorders and gastroparesis Hwoon-Yong Jung
(Seoul)
11:10-11:30 Endoscopic treatment of GERD John E. Pandolfino
(Chicago)
11:30-11:50 Surgical treatment of GERD and Achalasia TBA
11:50-12:00 Q&As
Symposium EN-9 (PB)
Nov. 17 (Sat)
10:30-12:00
Toward the new era of pancreatobiliary endoscopy 104
Chairperson(s) Sung-Koo Lee, Bing Hu
10:30-10:50 Best way of EUS-guided Tissue acquisition TBA
10:50-11:10 Current EUS-guided local therapy for PB tumor TBA
11:10-11:30 Optimal EUS-guided drainage in PB disease. TBA
11:30-11:50 Endoscopic treatment of biliary tract cancer; RFA & PDT D. Nageshwar Reddy
(Hyderabad)
11:50-12:00
Symposium SM-2
Nov. 17 (Sat)
10:30-12:00
Updates on liver transplantation 105
Chairperson(s) TBA, Boon Koon Yoong
10:30-10:50 How to decide when to go for liver transplantation Ray W. Kim
(Stanford)
10:50-11:10 Laparoscopic donor hepatectomy; safe and feasible? TBA
11:10-11:30 Expanding the indication; tumor and patient factor Kenneth Chok
(Hong Kong)
11:30-11:50 Expanding the indication; overcoming the donor shortage problems TBA
11:50-12:00 Q&As
Symposium EN-10 (LG)
Nov. 17 (Sat)
10:30-12:00
Screening and diagnosis of colon cancer: current and future 202
Chairperson(s) TBA, Hermann Brenner
10:30-10:50 Screening based on fecal test: From blood to DNA Young-Seok Cho
(Seoul)
10:50-11:10 Role of CT colonography for screening method Min Joo Kim
(Seoul)
11:10-11:30 Screening colonoscopy: Pros and Cons Hermann Brenner
11:30-11:50 Artificial intelligence for endoscopic diagnosis of colorectal neoplasia TBA
11:50-12:00 Q&As
Symposium LV-6
Nov. 17 (Sat)
14:00-15:30
Recent changes in the diagnosis and management of liver cirrhosis complication 101
Chairperson(s) Barjesh C Sharma, TBA
14:00-14:20 Evolving definition and treatment paradigms of acute-on-chronic liver failure Shiv K. Sarin
(New Delhi)
14:20-14:40 Minimal/overt hepatic encephalopathy: diagnostic tools, who should be treated, and how Ray W. Kim
(Stanford)
14:40-15:00 Management of refractory ascites Ashish Kumar
(New Delhi)
15:00-15:20 Recent advances in the management of variceal bleeding TBA
15:20-15:30 Q&As
Symposium GI-11 (LG)
Nov. 17 (Sat)
14:00-15:30
What are the special issues of IBD in Asians? 102
Chairperson(s) Mamoru Watanabe, TBA
14:00-14:20 Pathophysiologic mechanisms: Genetics and serology in Asian IBD patients TBA
14:20-14:40 Differential diagnosis of IBD and IBD mimics in Asia Shu Chen Wei
(Taipei)
14:40-15:00 Prognostication of Asian IBD patients: Different from Westerns? Zhihua Ran
(Shanghai)
15:00-15:20 Therapueutic algorithm in Asia vs. Western: Similarities and differences Katsuyoshi Matsuoka
(Tokyo)
15:20-15:30 Q&As
Symposium GI-12 (UG)
Nov. 17 (Sat)
14:00-15:30
GERD: new diagnostic approach and management in 2018 103
Chairperson(s) Sabine Roman, Young-Tae Bak
14:00-14:20 Pathophysiology of GERD: what’s new in 2018 ? John E. Pandolfino
(Chicago)
14:20-14:40 Novel diagnostic approach of GERD: From Ascona to Lyon consensus Sabine Roman
(Lyon)
14:40-15:00 The risk and benefits of long-term use of PPIs TBA
15:00-15:20 Potassium-competitive acid blockers (P-CAB): Advanced therapeutic option for GERD TBA
15:20-15:30 Q&As
Symposium-Nursing
Nov. 17 (Sat)
14:00-15:30
Current hot topic 104
Chairperson(s) Hee Hyuk Im, Hui-jun Xi
14:00-14:20 Endoscope reprocessing: trend, standard, process innovation TBA
14:20-14:40 Nursing of Sedative endoscopy Mei Yin Wong
(Hong Kong)
14:40-15:00 The effect of microbiology detection in endoscopic quality control Hui-jun Xi
(Shanghai)
15:00-15:20 Fecal microbiota transplantation Woo Joo Noh
(Seoul)
15:20-15:30 Q&As
Symposium EN-11 (PB)
Nov. 17 (Sat)
14:00-15:30
Management of pain in chronic pancreatitis: An update 202
Chairperson(s) Yong-Tae Kim, Yousuke Nakai
14:00-14:20 overview of pain mechanism and medical management of chronic pancreatitis TBA
14:20-14:40 endoscopic treatment of painful chronic pancreatitis (stricture and stone) D. Nageshwar Reddy
(Hyderabad)
14:40-15:00 Surgical treatment of painful chronic pancreatitis Joon Seong Park
(Seoul)
15:00-15:20 case discussion Jae Hee Cho
(Incheon)
15:20-15:30 Q&As
Symposium GI-13 (GI Cancer)
Nov. 17 (Sat)
14:00-15:30
Emerging armamentarium for the management of GI cancer 203
Chairperson(s) TBA, Myung Hwan Noh
14:00-14:20 Liquid biopsies: technology overview and clinical implications Dong Uk Kim
(Yangsan)
14:20-14:40 Revisiting an old weapon: HIPEC for GI cancer TBA
14:40-15:00 Immune therapy: Is this ready for use in GI cancer? Yusuke Hashimoto
(Kashiwa)
15:00-15:20 Proton beam therapy or Particle beam therapy Tae Hyun Kim
(Goyang)
15:20-15:30 Q&As
Symposium GI-14 (UG)
Nov. 17 (Sat)
16:00-17:30
What clinicians need to know in ROME IV? 101
Chairperson(s) Kentaro Sugano, Justin C.Y. Wu
16:00-16:20 Introduction and overview Nicholas Talley
(Callaghan)
16:20-16:40 Esophageal disorders Hiroto Miwa
(Nishinomiya)
16:40-17:00 Gastroduodenal disorders Nicholas Talley
(Callaghan)
17:00-17:20 Bowel disorders Suck Chei Choi
(Iksan)
17:20-17:30 Q&As
Symposium GI-15 (LG)
Nov. 17 (Sat)
16:00-17:30
Emerging issues in colorectal cancer screening in Asian-Pacific region 102
Chairperson(s) Khean-Lee Goh, Uri Ladabaum
16:00-16:20 Colorectal cancer screening guidelines and practice in Asia-Pacific TBA
16:20-16:40 Recent updates in biological markers in colorectal cancer screening Joseph JY Sung
(Hong Kong)
16:40-17:00 Obstacles and inequities in colorectal cancer screening in Asian-Pacific regions TBA
17:00-17:20 Cost-effectiveness of colorectal cancer screening Hermann Brenner
17:20-17:30 Q&As
AI Advances Endoscopy
Nov. 17 (Sat)
16:00-17:30
Artificial intelligence advances endoscopy 103
Chairperson(s) Mahesh Goenka, Hisao Tajiri
16:00-16:20 Convolutional neural network technology for polyp detection Namkug Kim
(Seoul)
16:20-16:40 Computer-aided analysis for polyp classification Peng-Jen Chen
(Taipei)
16:40-17:00 Computer-aided system (EndoBRAIN) for polyp characterization TBA
17:00-17:20 Endocytoscopy TBA
17:20-17:30 Q&As
Symposium-Nutrition
Nov. 17 (Sat)
16:00-17:30
Advances in nutritional therapy 104
Chairperson(s) Cho Hyun Park, TBA
16:00-16:20 Nutritional modulation of immune function Jae Hak Kim
(Goyang)
16:20-16:40 Immune modulating enteral & parenteral nutrition support (formula) TBA
16:40-17:00 Nutritional support for surgical patients TBA
17:00-17:20 Nutritional support for critically ill patients TBA
17:20-17:30 Q&As
Symposium SM-3
Nov. 17 (Sat)
16:00-17:30
Approaches to the Improving Survival of Advanced Colorectal Cancer 105
Chairperson(s) TBA, Michael Li
16:00-16:20 How do we proceed adequate multidisciplinary team? Taiwan experience David, Tao-Wei Ke
(Taichung)
16:20-16:40 Neoadjuvant chemotherapy: Can we omit radiation therapy? Jung-Myun Kwak
(Seoul)
16:40-17:00 RFA: a non-surgical alternative for colorectal liver metastasis TBA
17:00-17:20 Optimal application of HIPEC for colorectal cancer with peritoneal carcinomatosis Wai Lun Law
(Hong Kong)
17:20-17:30 Q&As
Symposium EN-12 (PB)
Nov. 17 (Sat)
16:00-17:30
Recent progress in management of difficult CBD stone removal 202
Chairperson(s) Chang Duck Kim, TBA
16:00-16:20 Current status of EPLBD in Korea Seok Jeong
(Incheon)
16:20-16:40 What's new in peroral cholangioscopy and EUS-guided therapy for CBD stone management? Yousuke Nakai
(Tokyo)
16:40-17:00 Laparoscopic approach for difficultr CBD stone management TBA
17:00-17:20 Endoscopic management of recurrent CBD stones: how to minimize the risk of recurrence? Sang Hyub Lee
(Seongnam)
17:20-17:30 Q&As
Symposium GI-16 (Editor)
Nov. 17 (Sat)
16:00-17:30
An editor’s view point. 203
Chairperson(s) TBA, TBA
16:00-16:20 Things to consider before submitting a manuscript TBA
16:20-16:40 How to write an attractive abstract Richard Peek
(Nashville)
16:40-17:00 How to write a reviewer report Eun Young Kim
(Daegu)
17:00-17:20 Common reasons for rejection Emad El-Omar
(Kogarah)
17:20-17:30 Q&As
Symposium SM-4
Nov. 18 (Sun)
08:30-10:00
Metablic & bariatric surgery 101
Chairperson(s) TBA, TBA
08:30-08:50 Surgical techniques of bariatric surgery: gastric band, sleeve gastrectomy, and gastric bypass Chih-Kun Huang
(Taichung)
08:50-09:10 Management of postoperative complications and bariatric emergencies TBA
09:10-09:30 Management for treatment failure with bariatric medication Min Young Cho
(Seoul)
09:30-09:50 Long-term follow up and management of nutritional deficiency after bariatric surgery TBA
09:50-10:00 Q&As
Symposium EN-13 (LG)
Nov. 18 (Sun)
08:30-10:00
Recent advances in radiologic and endoscopic monitoring of IBD 103
Chairperson(s) Takanori Kanai, TBA
08:30-08:50 Cutting edge of radilogic evaluation of IBD Se Hyung Kim
(Seoul)
08:50-09:10 Endoscopic grading systems in IBD Vineet Ahuja
(New Delhi)
09:10-09:30 Management of colorectal dysplaisa in IBD Kenji Watanabe
(Nishinomiya)
09:30-09:50 Clinical monitoring of pediatric IBD Yen-Hsuan Ni
(Taipei)
09:50-10:00 Q&As
Best of DDW 1
Nov. 18 (Sun)
08:30-10:00
Best of DDW 01 104+105
Chairperson(s) Myungkyu Choi, Timothy Wang
08:30-08:55 Helicobacter pylori Richard Peek
(Nashville)
08:55-09:20 Functional GI disorder and microbiome Emad El-Omar
(Kogarah)
09:20-09:45 NSAIDs and peptic ulcer bleedin TBA
09:45-10:00 Q&As
Symposium GI-17 (UG)
Nov. 18 (Sun)
10:30-12:00
Recent issues in diagnostic and therapeutic endoscopy 101
Chairperson(s) TBA, Kenshi Yao
08:30-08:50 E-learning system for increasing diagnostic performance in early gastric cancer Kenshi Yao
(Fukuoka)
08:50-09:10 Robot-assisted endoscopic resection Khek?Yu Ho
(Singapore)
09:10-09:30 Quality of ESD: It's time to look back TBA
09:30-09:50 Satety of endoscopic treatment for GISTs TBA
09:50-10:00 Q&As
Symposium GI-18 (UG)
Nov. 18 (Sun)
10:30-12:00
Current understanding of peptic ulcer disease 103
Chairperson(s) Jaw-Town Lin, TBA, Ian Roberts-Thomson
08:30-08:50 Pathophysiology and treatment of peptic ulcer
08:50-09:10 Helicobacter-negative peptic ulcer: the prevention and treatment Khien Vu Van
(Hanoi)
09:10-09:30 Risk assessment of peptic ulcer bleeding in the era of direct oral anticoagulants Akiko Shiotani
(Tokyo)
09:30-09:50 Endoscopic management of peptic ulcer bleeding: recent update Sunny H. Wong
(Hong Kong)
09:50-10:00 Q&As
Best of DDW 2
Nov. 18 (Sun)
10:30-12:00
Best of DDW 02 104+105
Chairperson(s) Won Ho Kim, Timothy Wang
10:30-10:55 Novel endoscopy TBA
10:55-11:20 Colorectal cancer Uri Ladabaum
(Stanford)
11:20-11:45 Inflammatory bowel disease TBA
11:45-12:00 Q&As
Symposium LV-7
Nov. 18 (Sun)
13:30-15:00
Recent advances in liver diseases 101
Chairperson(s) Osamu Yokosuka, Narci Teoh
13:30-13:50 Autoimmune hapatitis and primary biliary cholangitis TBA
13:50-14:10 Alcoholic liver disease and fecal transplant Shiv K. Sarin
(New Delhi)
14:10-14:30 Cholestatic liver disease Jidong Jia
(Beijing)
14:30-14:50 Update in drug induced liver injury Harshad?Devarbhavi
(Bengaluru)
14:50-15:00 Q&As
Symposium GI-19 (LG)
Nov. 18 (Sun)
13:30-15:00
IBS: update 2018 103
Chairperson(s) Minhu Chen, TBA
13:30-13:50 Low FODMAP diet: what we know in 2018 Peter R. Gibson
(Melbourne)
13:50-14:10 Post-infectious IBS: its mechanism and clinical course Hyo Jin Park
(Seoul)
14:10-14:30 Psychosomatic approach for IBS Shin Fukudo
(Sendai)
14:30-14:50 Microbiota in IBS: friend or foe? Eamonn Quigley
(Houston)
14:50-15:00 Q&As
Symposium PB-5
Nov. 18 (Sun)
13:30-15:00
Recent advances in malignant pancreatobiliary diseases 104
Chairperson(s) Dadang Makmun, Si Young Song
13:30-13:50 How to find out the early detection of pancreatobiliry cancer Khek-Yu Ho
(Singapore)
13:50-14:10 Optical endoscopic management of Borderline non-resectable pancreatic cancer TBA
14:10-14:30 Optical management of borderline resectable pancreatic cancer Hidenori Takahashi
(Osaka)
14:30-14:50 Current Status and Future Directions in Chemotherapy for pancreatiBiliary Tract Cancer Seung Woo Park
(Seoul)
14:50-15:00 Q&As
Early-Bird
Registration Deadline
August 12, 2018
Pre-Registration
Deadline
September 30, 2018